Fracture prevention in patients with cognitive impairment presenting with a hip fracture: secondary analysis of data from the HORIZON Recurrent Fracture Randomised Controlled Trial

PURPOSE: Patients with cognitive impairment (CI) are at high risk of fracture but often denied osteoporosis therapy. We tested whether the effects of zoledronic acid (Zol) on re-fracture and mortality differed in patients presenting with a hip fracture by cognitive status. METHODS: We used data from...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Hoofdauteurs: Prieto-Alhambra, Daniel, Judge, Andrew, Arden, Nigel K, Cooper, Cyrus, Lyles, KW, Javaid, M Kassim
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: 2013
Onderwerpen:
Article
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC3867338/
https://ncbi.nlm.nih.gov/pubmed/23812596
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00198-013-2420-8
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items